Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
<!-- Name:DistributionId Value:8799054 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
ABSCI Corporation
Absci Enters Multi-Program Collaboration with Emerging Biotech Partner
VANCOUVER, Wash. and NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology…